[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline",
    "summary": "PRINCETON, N.J., December 09, 2024--Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline",
    "url": "https://finnhub.io/api/news?id=4c7cfdb46047b216f23ebc7c81f7a6160dfa059af51b9aacd4a0164e23eed656",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733784300,
      "headline": "Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline",
      "id": 131892683,
      "image": "https://s.yimg.com/ny/api/res/1.2/U1Xe0HsRlSEvqB2V2aXcDQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xNjU-/https://media.zenfs.com/en/business-wire.com/a2a94d009421d5b1a1b5a113ce5fb5b9",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., December 09, 2024--Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline",
      "url": "https://finnhub.io/api/news?id=4c7cfdb46047b216f23ebc7c81f7a6160dfa059af51b9aacd4a0164e23eed656"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=ead9b768e426230a91333a17f0626d643fca723a260ef85b2ff324f1e93af0f3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733762460,
      "headline": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors",
      "id": 131936279,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=ead9b768e426230a91333a17f0626d643fca723a260ef85b2ff324f1e93af0f3"
    }
  },
  {
    "ts": null,
    "headline": "SCHD ETF: It Is Boring, And You Can Do Much Better - Is It For You?",
    "summary": "Schwab U.S. Dividend Equity ETF is a reliable and stress-free investment option for conservative, long-term investors. Find out why SCHD remains a Buy.",
    "url": "https://finnhub.io/api/news?id=5654415599c12e0851a87cdde14be8e9ce6ea59952dcd1a8fd8387bb515944e2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733755719,
      "headline": "SCHD ETF: It Is Boring, And You Can Do Much Better - Is It For You?",
      "id": 131872897,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1780363729/image_1780363729.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Schwab U.S. Dividend Equity ETF is a reliable and stress-free investment option for conservative, long-term investors. Find out why SCHD remains a Buy.",
      "url": "https://finnhub.io/api/news?id=5654415599c12e0851a87cdde14be8e9ce6ea59952dcd1a8fd8387bb515944e2"
    }
  }
]